ABBOTT INDIA
Back to Balance Sheet
|
ABBOTT INDIA Last 5 Year Total Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹5,902 Cr | ₹5,178 Cr | ₹4,539 Cr | ₹4,207 Cr | ₹3,823 Cr |
What is the latest Total Liabilities ratio of ABBOTT INDIA ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹5,902 Cr |
| Mar2024 | ₹5,178 Cr |
| Mar2023 | ₹4,539 Cr |
| Mar2022 | ₹4,207 Cr |
| Mar2021 | ₹3,823 Cr |
How is Total Liabilities of ABBOTT INDIA Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹5,902 Cr | 14.00 | |
| Mar2024 | ₹5,178 Cr | 14.08 | |
| Mar2023 | ₹4,539 Cr | 7.88 | |
| Mar2022 | ₹4,207 Cr | 10.06 | |
| Mar2021 | ₹3,823 Cr | - | |
Compare Total Liabilities of peers of ABBOTT INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ABBOTT INDIA | ₹54,802.8 Cr | 2.2% | -1.7% | -22.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,989.0 Cr | 1.7% | 6.4% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,471.0 Cr | 3% | 2.8% | 0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,290.0 Cr | 2.3% | 9.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹117,820.0 Cr | 0.3% | 6.1% | -3.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,730.0 Cr | -0.1% | 8.9% | 1.9% | Stock Analytics | |
ABBOTT INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ABBOTT INDIA | 2.2% |
-1.7% |
-22.4% |
| SENSEX | 0.9% |
4.2% |
-6% |
You may also like the below Video Courses